期刊文献+

兰州市社区中老年2型糖尿病患者糖化血红蛋白控制状况影响因素 被引量:7

The control status of glycosylated hemoglobin and its influencing factors in the middle aged and elderly patients with type 2 diabetes mellitus in Lanzhou communities
原文传递
导出
摘要 目的 了解兰州市社区中老年2型糖尿病(T2DM)患者糖化血红蛋白(HbA1c)控制状况并分析其相关影响因素.方法 整群抽取兰州市社区40~75岁已诊断为T2DM的患者1 120例纳入研究,对其进行问卷调查,并测量身高、体质量、血压、血脂及HbA1c,计算体质量指数(BMI),进行统计分析.结果 1 120例患者中HbA1c达标(HbA1c<7.0%)者453例,占40.4%(453/1 120);未达标(HbA1c≥7.0%)者667例,占59.6%(667/1 120).在单纯生活方式、一种口服药、多种口服药及胰岛素治疗的患者中,HbA1c达标率分别为49.2%(94/191),45.7%(182/398),41.5%(88/212)和27.9%(89/319);伴超重(BMI 24.1~ 28.0 kg/m2)或肥胖(BMI> 28.0 kg/m2)、合并大血管或微血管并发症的患者HbA1c达标率低于不伴超重或肥胖、未合并大血管或微血管并发症的患者[38.6% (192/498),32.2%(49/152)比60.0%(12/20),44.4%(200/450); 32.7%(49/150)比41.6%(404/970); 27.0%(85/315)比45.7%(368/805)],差异有统计学意义(P<0.01或<0.05).多因素Logistic回归分析显示,糖尿病病程的延长、BMI的升高、合并微血管并发症及治疗方式逐步加强是HbA1c不达标的独立影响因素(P<0.05).结论 兰州市社区中老年T2DM患者HbA1c达标情况不容乐观;血糖的控制受多种因素的影响,故应进一步加强糖尿病管理,优化治疗方案,注重个体化综合治疗,以有效改善患者血糖控制状况. Objective To investigate the control status of glycosylated hemoglobin (HbA1c) in the middle aged and elderly patients with type 2 diabetes mellitus (T2DM) in Lanzhou communities and analyze its influencing factors.Methods A total of 1 120 individuals having diagnosed T2DM aged 40-75 years in Lanzhou communities were selected.Questionnaire was conducted.Height,weight,blood pressure and lipid were examined.Body mass index (BM1) was calculated.The index were analyzed.Results The patients with HbA1c less than 7.0% were 453 cases (40.4%,453/1 120),and HbA1c more than or equal to 7.0% were 667cases (59.6%,667/1 120).The target rate of HbA1c in the patients receiving life style,one oral antidiabetic drug,more oral antidiabetic drug,insulin therapy were 49.2%(94/191),45.7%(182/398),41.5%(88/212) and 27.9%(89/319),respectively.The target rate of HbA1c were 38.6%(192/298),32.2%(49/152),32.7%(49/150),27.0%(85/315) in the patients overweight or obese,with macro or micro vascular complication,and 60.0% (12/20),44.4%(200/450),41.6%(404/970),45.7%(368/805) in the patients without overweight or obese and macro or micro vascular complication,and there were significant differences (P 〈 0.01 or 〈 0.05).Multivariate Logistic regression analysis showed that the extension duration of diabetes,increased BMI,combining with macro or micro vascular complication and gradual strengthening antidiabetic treatment were independent risk factors for HbA1c target (P 〈 0.05).Conclusions Current status of HbA1c control in the middle aged and elderly patients with T2DM in Lanzhou communities is not optimistic,which is affected by many factors,suggesting that professional education on management should be further strengthened.And optimal treatment programs and individualized comprehensive treatment are needed for most patients to improve glycemic control.
出处 《中国医师进修杂志》 2015年第2期111-115,共5页 Chinese Journal of Postgraduates of Medicine
基金 基金项目:中华医学会临床医学科研专项基金(10020120234) 甘肃省卫生行业科技计划(GSWST2010-03)
关键词 糖尿病 2型 胰岛素 糖化血红蛋白 影响因素 Diabetes mellitus, type 2 Insulin Glycosylated hemoglobin Influencing factors
  • 相关文献

参考文献15

  • 1Spitz AF, Kanani H. Change in HbAiC as a measure of quality ofdiabetes care[j]. Diabetes Care, 2006, 29(5): 1183-1184.
  • 2Turner RC, Holman RR, Cull CA, et al. Intensive blood-glucosecontrol with sulphonylureas or insulin compared with conventionaltreatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J]. Lancet, 1998, 352(9131): 837-853.
  • 3Giugliano D,Maiorino MI,Bellastella G, et al. Efficacy of insulinanalogs in achieving the hemoglobin Ale target of < 7% in type 2diabetes : meta-analysis of randomized controlled trials [ J ]. DiabetesCare, 2011, 34(2); 510-517.
  • 4American Diabetes Association. Standards of medical care indiabetes—2013[j]. Diabetes Care, 2013, 36 Suppl 1 : SI 1-66.
  • 5Ning G, Bloomgarden Z. Diabetes in China: prevalence,diagnosis, and control [j]. J Diabetes, 2013, 5(4): 372.
  • 6Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to controlrisk factors for cardiovascular disease in type 2 diabetes patients[J]. AmJMed, 2013,126(10): 925,el 1-22.
  • 7中华医学会糖尿病学分会.中国2型糖尿病防'冶指南(2010年版)[J].中华糖尿病杂志,2010,2增刊2: 1-56.
  • 8Huysman F, Mathieu C. Diabetes and peripheral vascular disease[J]. Acta Chirurgica Belgica, 2009, 109(5): 587-594.
  • 9胡晓霞,石红,胡彩虹,杨丽丽,何继瑞.兰州624例糖尿病患者糖化血红蛋白达标率筛查分析[J].中国老年学杂志,2011,31(12):2352-2352. 被引量:3
  • 10郭晓蕙,纪立农,陆菊明,杨文英,翁建平,贾伟平,邹大进,周智广,于德民,柳洁,单忠艳,杨玉芝,胡仁明,朱大龙,杨立勇,陈丽,赵志刚,李启富,田浩明,姬秋和,刘静,葛家璞,时立新,徐焱成.2009年中国成人2型糖尿病患者口服降糖药联合胰岛素治疗后血糖达标状况调查[J].中华糖尿病杂志,2012,4(8):474-478. 被引量:71

二级参考文献24

  • 1潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:396
  • 2International Diabetes Federation. The global burden:diabetes and impaired glucose tolerance (IGT)[EB/OL].http://www.idf.org/diabetesatlas/5e/the-globalburden,2012.
  • 3Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010.1090-1101.
  • 4UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].The Lancet,1998.837-853.
  • 5Yang WY,Lu JM,Weng JP. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010.1090-1101.
  • 6UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33)[J].The Lancet,1998.837-853.
  • 7World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects-Last amended by the 59th WMA General Assembly,Seoul 2008[OL].http://www.wma.net/e/policy/b3.htm,2008.
  • 8Pan CY,Yang WY,Jia WP. Managment of Chinese patients with type 2 diabetes mellitus,1998-2006:the DiabetesChina surveys[J].Current Medical Research and Opinion,2009.39-45.
  • 9Valensi P,Benroubi M,Borzi V. The IMPROVETM studya multinational,observational study in type 2 diabetes:baseline characteristics from eight national cohort[J].International Journal of Clinical Practice,2008.1809-1819.
  • 10Holman RR,Paul SK,Bethel MA. 10-year follow up of intensive glucose control in type 2 diabetes[J].New England Journal of Medicine,2008.1577-1589.

共引文献156

同被引文献72

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部